Ning Zu

624 total citations · 1 hit paper
17 papers, 442 citations indexed

About

Ning Zu is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ning Zu has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ning Zu's work include Diabetes Treatment and Management (5 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Ning Zu is often cited by papers focused on Diabetes Treatment and Management (5 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Ning Zu collaborates with scholars based in China, Denmark and South Korea. Ning Zu's co-authors include Guochun Wang, Lu Zhang, Li Ma, Freddy G. Eliaschewitz, Ming Liu, Soo Lim, Linong Ji, Yufeng Li, Yuewen Gong and Xiaolin Dong and has published in prestigious journals such as Diabetes, The Lancet Diabetes & Endocrinology and CrystEngComm.

In The Last Decade

Ning Zu

17 papers receiving 438 citations

Hit Papers

Efficacy and safety of once weekly semaglutide 2·4 mg for... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
    2024 59 citations Yiming Mu, Freddy G. Eliaschewitz et al. The Lancet Diabetes & Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Zu China 10 198 134 127 98 72 17 442
Na Yang China 10 66 0.3× 108 0.8× 161 1.3× 24 0.2× 22 0.3× 25 421
Jochen Ittner Germany 6 111 0.6× 292 2.2× 159 1.3× 12 0.1× 99 1.4× 7 577
Patricia Restituto Spain 10 67 0.3× 97 0.7× 84 0.7× 16 0.2× 63 0.9× 13 385
Maxi Meissner Netherlands 9 118 0.6× 219 1.6× 144 1.1× 30 0.3× 190 2.6× 11 721
Izumi Iseda Japan 6 181 0.9× 69 0.5× 42 0.3× 38 0.4× 38 0.5× 11 345
Jiangtao Yan China 12 62 0.3× 159 1.2× 80 0.6× 13 0.1× 90 1.3× 23 460
Vasiliki Mavroeidi Greece 8 70 0.4× 95 0.7× 61 0.5× 36 0.4× 18 0.3× 16 311
Matthew M. Goodman United States 14 66 0.3× 198 1.5× 351 2.8× 39 0.4× 26 0.4× 23 675
Lara Valiño‐Rivas Spain 14 42 0.2× 225 1.7× 44 0.3× 62 0.6× 34 0.5× 23 602
Takeo Sakuta Japan 8 87 0.4× 58 0.4× 16 0.1× 166 1.7× 78 1.1× 15 410

Countries citing papers authored by Ning Zu

Since Specialization
Citations

This map shows the geographic impact of Ning Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Zu more than expected).

Fields of papers citing papers by Ning Zu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Zu. The network helps show where Ning Zu may publish in the future.

Co-authorship network of co-authors of Ning Zu

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Zu. A scholar is included among the top collaborators of Ning Zu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Zu. Ning Zu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gu, Weijun, Yibing Lu, Guoyue Yuan, et al.. (2025). Efficacy and safety of once‐weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial. Diabetes Obesity and Metabolism. 27(5). 2540–2551. 2 indexed citations
2.
3.
Mu, Yiming, Freddy G. Eliaschewitz, Morten Hansen, et al.. (2024). Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial. The Lancet Diabetes & Endocrinology. 12(3). 184–195. 59 indexed citations breakdown →
4.
5.
6.
Li, Min, et al.. (2017). Orexin A influence progesterone secreted and the content of cAMP in sheep ovarian granulosa cells.. Chinese Veterinary Science. 47(11). 1433–1440. 1 indexed citations
7.
Zu, Ning, et al.. (2017). A review of social media in education: effects and attitudes. 5(3). 191–191. 1 indexed citations
8.
Li, Li, et al.. (2017). A review of social media in education: effects and attitudes. 5(3). 191–191. 1 indexed citations
9.
Zhang, Lu, et al.. (2013). Left Ventricular Diastolic Dysfunction — Early Cardiac Impairment in Patients with Polymyositis/Dermatomyositis: A Tissue Doppler Imaging Study. The Journal of Rheumatology. 40(9). 1572–1577. 29 indexed citations
10.
Zu, Ning, et al.. (2013). Chylothorax and chylopericardium in Behçet’s diseases: case report and literature review. Clinical Rheumatology. 32(7). 1107–1111. 10 indexed citations
11.
Lu, Xin, et al.. (2012). Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis. Clinical Rheumatology. 31(12). 1691–1697. 30 indexed citations
12.
Zu, Ning, et al.. (2012). Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review. Clinical Rheumatology. 31(5). 801–806. 47 indexed citations
13.
Zhang, Lu, Guochun Wang, Li Ma, & Ning Zu. (2012). Cardiac Involvement in Adult Polymyositis or Dermatomyositis: A Systematic Review. Clinical Cardiology. 35(11). 685–691. 129 indexed citations
14.
Zu, Ning, et al.. (2011). [The expression of the type I interferon system in muscle and lung of autoimmune myositis rat model].. PubMed. 50(10). 868–72. 2 indexed citations
15.
16.
Li, Ping, Yuewen Gong, Ning Zu, et al.. (2005). Therapeutic Mechanism of Saikosaponin-d in Anti-Thy1 mAb 1-22-3-Induced Rat Model of Glomerulonephritis. Nephron Experimental Nephrology. 101(4). e111–e118. 26 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Na Yang Breakdown of academic impact, for papers by Jochen Ittner Breakdown of academic impact, for papers by Patricia Restituto Breakdown of academic impact, for papers by Maxi Meissner Breakdown of academic impact, for papers by Izumi Iseda Breakdown of academic impact, for papers by Jiangtao Yan Breakdown of academic impact, for papers by Vasiliki Mavroeidi Breakdown of academic impact, for papers by Matthew M. Goodman Breakdown of academic impact, for papers by Lara Valiño‐Rivas Breakdown of academic impact, for papers by Takeo Sakuta
Rankless by CCL
2026